The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide - PubMed (original) (raw)
The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide
M W Radomski et al. Br J Pharmacol. 1987 Nov.
Abstract
1. The interactions between endothelium-derived nitric oxide (NO) and prostacyclin as inhibitors of platelet aggregation were examined. 2. Porcine aortic endothelial cells treated with indomethacin and stimulated with bradykinin (10-100 nM) released NO in quantities sufficient to account for the inhibition of platelet aggregation attributed to endothelium-derived relaxing factor (EDRF). 3. In the absence of indomethacin, stimulation of the cells with bradykinin (1-3 nM) released small amounts of prostacyclin and EDRF which synergistically inhibited platelet aggregation. 4. EDRF and authentic NO also caused disaggregation of platelets aggregated either with collagen or with U46619. 5. A reciprocal potentiation of both the anti- and the dis-aggregating activity was also observed between low concentrations of prostacyclin and authentic NO or EDRF released from endothelial cells. 6. It is likely that interactions between prostacyclin and NO released by the endothelium play a role in the homeostatic regulation of platelet-vessel wall interactions.
Similar articles
- Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.
Radomski MW, Palmer RM, Moncada S. Radomski MW, et al. Br J Pharmacol. 1987 Sep;92(1):181-7. doi: 10.1111/j.1476-5381.1987.tb11310.x. Br J Pharmacol. 1987. PMID: 3311265 Free PMC article. - Platelet inhibition by endothelium-derived relaxing factor from the rabbit perfused aorta.
Bult H, Fret HR, Van den Bossche RM, Herman AG. Bult H, et al. Br J Pharmacol. 1988 Dec;95(4):1308-14. doi: 10.1111/j.1476-5381.1988.tb11769.x. Br J Pharmacol. 1988. PMID: 3064856 Free PMC article. - Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells.
Gryglewski RJ, Moncada S, Palmer RM. Gryglewski RJ, et al. Br J Pharmacol. 1986 Apr;87(4):685-94. doi: 10.1111/j.1476-5381.1986.tb14586.x. Br J Pharmacol. 1986. PMID: 3085757 Free PMC article. - Vasoactive mediators derived from the endothelium.
Botting R, Vane JR. Botting R, et al. Arch Mal Coeur Vaiss. 1989 Nov;82 Spec No 4:11-4. Arch Mal Coeur Vaiss. 1989. PMID: 2514650 Review.
Cited by
- Mechanisms of nitric oxide in spinal cord injury.
Hao J, Ye Y, Zhang G, Shen H, Li J, Chen G. Hao J, et al. Med Gas Res. 2024 Dec 1;14(4):192-200. doi: 10.4103/mgr.MEDGASRES-D-23-00006. Epub 2024 Mar 28. Med Gas Res. 2024. PMID: 39073327 Free PMC article. Review. - Endothelium-Derived Dopamine and 6-Nitrodopamine in the Cardiovascular System.
Zatz R, De Nucci G. Zatz R, et al. Physiology (Bethesda). 2024 Jan 1;39(1):44-59. doi: 10.1152/physiol.00020.2023. Epub 2023 Oct 24. Physiology (Bethesda). 2024. PMID: 37874898 Free PMC article. Review. - Experimental Models of Traumatic Injuries: Do They Capture the Coagulopathy and Underlying Endotheliopathy Induced by Human Trauma?
Barrett L, Curry N, Abu-Hanna J. Barrett L, et al. Int J Mol Sci. 2023 Jul 6;24(13):11174. doi: 10.3390/ijms241311174. Int J Mol Sci. 2023. PMID: 37446351 Free PMC article. Review. - Role of Nitric Oxide in Megakaryocyte Function.
Asgari A, Jurasz P. Asgari A, et al. Int J Mol Sci. 2023 May 2;24(9):8145. doi: 10.3390/ijms24098145. Int J Mol Sci. 2023. PMID: 37175857 Free PMC article. Review.
References
- Prostaglandins. 1978 Mar;15(3):383-97 - PubMed
- Br J Pharmacol. 1982 May;76(1):3-31 - PubMed
- Prostaglandins. 1982 Apr;23(4):579-89 - PubMed
- Thromb Res. 1983 May 15;30(4):383-9 - PubMed
- Annu Rev Pharmacol Toxicol. 1984;24:175-97 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous